ADMs proprietary research backed these offerings, stating that 83% of GLP-1 users prefer food products marketed as supportive of their medication needs
Stepping-Stones Towards Triple Agonism: A Summary of GLP-1/GIP and GLP-1/GCG Dual-Agonist Development The development of triple agonists for obesity has built upon successes of several dual combinations of entero-pancreatic hormone receptor agonists, in particular, GLP-1/GIP dual agonists and GLP-1/GCG dual agonists
Meal Prep & Planning: Setting Yourself Up for Success With a reduced appetite, planning becomes even more important to ensure nutritional goals are met
Nanaimo, BC: April 12, 2026 Whitehorse, Yukon: October 24 & 25, 2026...two full days of live needling reps
Canada has seen significant growth in hormone optimization clinics over the past decade, with major cities like Toronto, Vancouver, Calgary, and Montreal all having multiple options for men seeking supervised testosterone therapy combined with comprehensive blood work monitoring